Health System Experiences and Care Engagement in Latine Patients With Hidradenitis Suppurativa. Read more about Health System Experiences and Care Engagement in Latine Patients With Hidradenitis Suppurativa.
Neighborhood Socioeconomic Status and New Hidradenitis Suppurativa Diagnoses in a Single Health System. Read more about Neighborhood Socioeconomic Status and New Hidradenitis Suppurativa Diagnoses in a Single Health System.
Skin Cancer Diagnosis by Lesion, Physician, and Examination Type: A Systematic Review and Meta-Analysis. Read more about Skin Cancer Diagnosis by Lesion, Physician, and Examination Type: A Systematic Review and Meta-Analysis.
Rosacea Core Domain Set for Clinical Trials and Practice: A Consensus Statement. Read more about Rosacea Core Domain Set for Clinical Trials and Practice: A Consensus Statement.
Patient Perspectives on Social Risk Screening and Documentation in a Dermatology Clinic. Read more about Patient Perspectives on Social Risk Screening and Documentation in a Dermatology Clinic.
Public Access to Scientific Research Findings and Principles of Biomedical Research-A New Policy for the JAMA Network. Read more about Public Access to Scientific Research Findings and Principles of Biomedical Research-A New Policy for the JAMA Network.
Prognostic Relevance of Dominant Blood T-Cell Clones in Early Mycosis Fungoides-Reply. Read more about Prognostic Relevance of Dominant Blood T-Cell Clones in Early Mycosis Fungoides-Reply.
Association of a Dominant T-Cell Clone in Peripheral Blood With Time to Systemic Treatment in Patients With Stage IB Mycosis Fungoides. Read more about Association of a Dominant T-Cell Clone in Peripheral Blood With Time to Systemic Treatment in Patients With Stage IB Mycosis Fungoides.
Widespread Erythematous Plaques With Prominent Telangiectases. Read more about Widespread Erythematous Plaques With Prominent Telangiectases.
Evaluation of Crizotinib Treatment in a Patient With Unresectable GOPC-ROS1 Fusion Agminated Spitz Nevi. Read more about Evaluation of Crizotinib Treatment in a Patient With Unresectable GOPC-ROS1 Fusion Agminated Spitz Nevi.
